Full-Time

Vice President

Business Development, Navista

Updated on 4/15/2025

Cardinal Health

Cardinal Health

Distributes pharmaceuticals and medical products globally

Compensation Overview

$163k - $263.2k/yr

+ Bonus

Expert

Company Does Not Provide H1B Sponsorship

United States

Candidates must be based in the U.S.

Category
Business Development
Business & Strategy
Requirements
  • Bachelor’s degree in business administration, healthcare administration, life sciences, or a related field preferred; advanced degree (MBA, Master’s in healthcare administration) preferred
  • 15+ in an executive strategy & development position, or similar title preferred
  • Demonstrated abilities for success in strategic development, business development, preferably in the healthcare industry, including identifying and evaluating market opportunities, and developing business plans for expansion & growth
  • Excellent communication and presentation skills, with the ability to effectively convey the network’s mission and impact with physicians, staff and internal stakeholders
  • Familiarity with the field of Oncology including trends, healthcare regulations, treatment modalities, and research advancements
  • Strong business acumen and financial background, to ensure efficient allocation of resources and maximize returns on investments
  • Experience with leading and managing diverse teams, including hiring, training and evaluating performance
  • Strong analytical and problem-solving abilities
  • Ability to travel up to 50%
Responsibilities
  • Oversee the commercial operations & strategy division, to develop and execute comprehensive strategic development plans aligned with the networks mission and growth objectives
  • Identify opportunities for expansion, partnerships and programmatic enhancements to advance the networks presence and impact
  • Identify and foster relationships with healthcare providers, research institutions and other key stakeholders
  • Define strategic pipeline including opportunities for growth and new revenue streams, such as service line expansion, entering new markets or developing innovative programs
  • Collaborates with marketing and communications on the development and implementation of branding and marketing strategies to enhance the networks visibility & reputation through development of compelling messaging, promotional materials, and public relations initiatives.
  • Partners with Corporate Development on identifying and evaluating potential new practices and partnership
  • Develops and maintains strong relationships with key stakeholders, including internal sales team to drive the overall oncology strategy
  • Responsible for sales operations and leading and developing a team
  • Negotiates contracts and agreements
  • Proven track record of leading Teams responsible for growth through acquisitions, partnerships, and service line expansion.
  • Strong understanding of practice management, operations, and healthcare regulations
Desired Qualifications
  • Bachelor’s degree in business administration, healthcare administration, life sciences, or a related field preferred; advanced degree (MBA, Master’s in healthcare administration) preferred
  • 15+ in an executive strategy & development position, or similar title preferred

Cardinal Health distributes pharmaceuticals and manufactures medical and laboratory products for healthcare facilities. The company provides essential medical supplies and performance solutions to enhance operational efficiency and patient care. With over 50 years of experience, Cardinal Health operates in more than 30 countries and employs around 48,000 people. Its business model focuses on selling to hospitals, clinics, and other healthcare providers, making it a key player in the healthcare supply chain. Cardinal Health stands out from competitors due to its extensive global network and comprehensive range of products, aiming to improve healthcare delivery.

Company Size

N/A

Company Stage

N/A

Total Funding

$270.6M

Headquarters

Dublin, California

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for telehealth solutions complements Cardinal Health's data solutions and patient care.
  • Hospital-at-home models offer Cardinal Health opportunities to expand service offerings.
  • Specialty pharmaceuticals demand aligns with Cardinal Health's acquisition of Specialty Networks.

What critics are saying

  • Increased competition from digital health startups like RxLive challenges Cardinal Health's model.
  • Integration challenges from acquiring Specialty Networks may disrupt Cardinal Health's operations.
  • Expansion in Indianapolis could lead to increased operational costs without guaranteed ROI.

What makes Cardinal Health unique

  • Cardinal Health's acquisition of Specialty Networks enhances its specialty pharmaceutical distribution capabilities.
  • The company's global operations in over 30 countries strengthen its supply chain network.
  • Cardinal Health's investment in Medically Home supports leadership in hospital-level patient care at home.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Health Savings Account/Flexible Spending Account

401(k) Retirement Plan

401(k) Company Match

Short- and Long-term Disability Coverage

Paid Parental Leave

Wellness Program

Company News

PR Newswire
Jan 31st, 2024
Cardinal Health To Acquire Specialty Networks And Its Pps Analytics Platform, A Technology Enabled Multi-Specialty Group Purchasing And Practice Enhancement Organization In Urology, Rheumatology And Gastroenterology

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices. Transaction creates platform for Cardinal Health expansion across specialty therapeutic areas. Transaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ NetworkDUBLIN, Ohio, Jan. 31, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization for $1.2B in cash. Specialty Networks creates clinical and economic value for independent specialty providers and partners across multiple specialty GPOs: UroGPO, Gastrologix and GastroGPO, and United Rheumatology

Intelligence360
Mar 7th, 2023
Cardinal Health To Spend $3,100,000.00 To Occupy 3,794 Square Feet Of Space In Indianapolis Indiana.

Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana. Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana.Indianapolis, Indiana — According to state and local economic development sources, Cardinal Health plans to invest $3,100,000.00 to build out 3,794 square feet of new space in Indianapolis. The company plans to occupy the new space at 7736 Zionsville Rd in Indianapolis, on or about September 1, 2023. According to the company website Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world

GlobeNewswire
Jul 26th, 2022
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients

Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem...

PR Newswire
Jan 10th, 2022
Medically Home Announces a $110 Million Strategic Investment Led by Baxter International Inc., Global Medical Response and Cardinal Health to Advance Leadership in Hospital-Level Patient Care at Home

/PRNewswire/ -- Medically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global...